These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 573131)

  • 1. Evidence that cells from experimental tumours can activate coagulation factor X.
    Curatolo L; Colucci M; Cambini AL; Poggi A; Morasca L; Donati MB; Semeraro N
    Br J Cancer; 1979 Aug; 40(2):228-33. PubMed ID: 573131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor X-activating activity from Lewis lung carcinoma.
    Hilgard P; Whur P
    Br J Cancer; 1980 Apr; 41(4):642-3. PubMed ID: 7387861
    [No Abstract]   [Full Text] [Related]  

  • 3. Activators of coagulation in cultured human lung-tumor cells.
    Seitz R; Heidtmann HH; Maasberg M; Immel A; Egbring R; Havemann K
    Int J Cancer; 1993 Feb; 53(3):514-20. PubMed ID: 8381396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reverse correlation between the functional state of the anticoagulating blood system and development of a malignant tumor].
    Kudriashov BA; Kalishevskaia TM; Kolomina SM
    Vopr Med Khim; 1969; 15(4):356-63. PubMed ID: 5351647
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for a warfarin-sensitive serum factor that participates in factor X activation by Lewis lung tumor cells.
    Fasco MJ; Wilson AC; Lincoln D; Gierthy J
    Int J Cancer; 1987 May; 39(5):631-7. PubMed ID: 3570555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy.
    Gieseler F; Lühr I; Kunze T; Mundhenke C; Maass N; Erhart T; Denker M; Beckmann D; Tiemann M; Schulte C; Dohrmann P; Cavaillé F; Godeau F; Gespach C
    Thromb Haemost; 2007 Jun; 97(6):1023-30. PubMed ID: 17549306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procoagulant activity of the MC28 fibrosarcoma cell line in vitro and in vivo.
    Amirkhosravi M; Francis JL
    Br J Haematol; 1993 Dec; 85(4):736-44. PubMed ID: 7918038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cell generation of thrombin via functional prothrombinase assembly.
    VanDeWater L; Tracy PB; Aronson D; Mann KG; Dvorak HF
    Cancer Res; 1985 Nov; 45(11 Pt 1):5521-5. PubMed ID: 4053025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum DNA binding protein in mice with cancer].
    Tong TJ
    Zhonghua Yi Xue Za Zhi; 1984 May; 64(5):291-3. PubMed ID: 6435825
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activation of the blood coagulation system during gram-negative infections and endotoxemias].
    Lüscher EF
    Fortschr Med; 1975 Aug; 93(22-23):1072-6. PubMed ID: 1225791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma tissue factor plus activated peripheral mononuclear cells activate factors VII and X in cardiac surgical wounds.
    Hattori T; Khan MM; Colman RW; Edmunds LH
    J Am Coll Cardiol; 2005 Aug; 46(4):707-13. PubMed ID: 16098440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.
    Stern DM; Nawroth PP; Kisiel W; Handley D; Drillings M; Bartos J
    J Clin Invest; 1984 Dec; 74(6):1910-21. PubMed ID: 6439737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of metastatic and primary tumor factor X activator capabilities by Lewis lung carcinoma cells cultured in vitamin K-dependent protein deficient serum.
    Fasco MJ; Eagan GE; Wilson AC; Gierthy JF; Lincoln DL
    Cancer Res; 1988 Nov; 48(22):6504-9. PubMed ID: 3180067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
    Lämmle B; Griffin JH
    Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary characterization of the procoagulant material in human ascites.
    Addonizio VP; Fisher CA; Strauss JF; Ewan VA; Rickles FR; Rosato EF; Harken AH; Inouye WY
    Surgery; 1987 Jun; 101(6):753-62. PubMed ID: 3589968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of platelet-derived β-thromboglobulins on coagulation.
    Egan K; van Geffen JP; Ma H; Kevane B; Lennon A; Allen S; Neary E; Parsons M; Maguire P; Wynne K; O' Kennedy R; Heemskerk JWM; Áinle FN
    Thromb Res; 2017 Jun; 154():7-15. PubMed ID: 28384443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of factor Xa in determining the procoagulant activity of whole-blood clots.
    Eisenberg PR; Siegel JE; Abendschein DR; Miletich JP
    J Clin Invest; 1993 May; 91(5):1877-83. PubMed ID: 8486759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation changes in mice bearing Lewis lung carcinoma, a metastasizing tumor.
    Poggi A; Polentarutti N; Benedetta Donati M; de Gaetano G; Garattini S
    Cancer Res; 1977 Jan; 37(1):272-7. PubMed ID: 830414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Warfarin inhibits both procoagulant activity and metastatic capacity of Lewis lung carcinoma cells. Role of vitamin K deficiency.
    Colucci M; Delaini F; de Bellis Vitti G; Locati D; Poggi A; Semeraro N; Donati MB
    Biochem Pharmacol; 1983 Jun; 32(11):1689-91. PubMed ID: 6870908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of fibrinogen and fibrin on thrombin generation--evidence for feedback activation of the clotting system by clot bound thrombin.
    Kumar R; Béguin S; Hemker HC
    Thromb Haemost; 1994 Nov; 72(5):713-21. PubMed ID: 7900079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.